elapsed_time: 18s
was_input_captured: False
original_text: |
    Any advanced solid tumor that has failed at least one line of therapy and is TMB-H (â‰¥10 mut/Mb, F1CDx assay), excluding dMMR/MSI-H tumors. Note: For participants to be eligible for enrollment they must have failed at least one line of standard of care systemic therapy (ie, not treatment naÃ¯ve), with the exception of CRC participants who must have failed at least 2 lines of standard of care systemic therapy, as per CRC specific eligibility criteria. Participants must not have melanoma or NSCLC.
inclusion: True
